PubMed Health⌕ Search

Biomedical subjects

F Vanara

Publications and source records attributed to F Vanara.

7 recordsLinked to original sources

Economic evaluation of ultrasound screening options for structural fetal malformations.

OBJECTIVE: To perform a cost-effectiveness analysis comparing the current Italian situation of no organized screening program for structural fetal malformations with an organized screening model involving a scan at 19-21 weeks of gestation. METHODS: Assumptions were made about the number of pregnant women examined per year, the number of ultrasound examinations (screening and diagnostic) and amniocenteses, the prevalence of fetal anomalies, ultrasound sensitivity and specificity and the rates of termination of pregnancy and of fetal death. The costs included procedures performed during and after the diagnosis of malformations, and the resources required to organize the program. Data sources were a literature review, estimates and national tariffs. A sensitivity analysis considered variations in screening test sensitivity, number of private scans and costs of ultrasound, fetal echocardiography, amniocentesis, care for malformed infants and organization. RESULTS: An organized program would increase the number of diagnosed malformations (+10.7%) and decrease the number of malformed infants (-19.9%). It would also decrease the total cost of screening, from 505 billion to 400 billion euros (-20.7%), decrease the cost per woman examined from 971 to 770 euros (-20.7%) and decrease the cost per malformed fetus diagnosed from 79,085 to 56,637 euros (-28.4%). CONCLUSIONS: In all scenarios considered, an organized program would lead to increased detection of malformations at lower cost. Further cost analyses should provide a better representation of resources used, especially those related to the care of malformed infants, while cost-benefit assessments should include all the consequences of prenatal diagnosis, such as those deriving from false results and those for both the woman and society, including ethical issues.

Abortion, Induced↗

[Cost analysis of a mammographic screening program].

In this paper we evaluate the principal direct costs (staff, capital and maintenance equipment, supplies, hardware and software system, mail, advertising campaign) of the mammographic screening programme "Prevenzione Serena" (Torino), from the recruitment time to the diagnostic assessments of screen positive cases. On the basis of the annual situation of a screening Unit which supplies two-view mammographies, read by two radiologists, and of a 60% attendance rate and a 5% recall rate, we estimate a total annual cost of 1.4 thousand million lire (875,000$), a cost per invited woman of 38,600 lire (24$), per tested woman of 64,400 lire (40$) and per breast cancer detected of 9.2 million lire (5,750$). Staff accounts for about 60% of the total cost. We evaluate also some alternative scenarios, with different hypothesis about the useful life of the equipment, the discount rate, the attendance and the recall rate.

Aged↗

[The economic evaluation of the early diagnosis of breast carcinoma: a review of the literature].

This paper reviews the economic aspects of screening for breast cancer: from a bibliographic search we identified studies on complete economic evaluation of screening programs in different parts of the world. At the methodological level, it goes as far as proposing a reference model for economic evaluation. An examination of the results obtained from various studies indicates that the introduction of screening program involves a cost per life-year saved of between 3,800 and 88,000 dollars. Allowing for quality of life, the range is 4,050 to 91,650 dollars. A discussion of some examples of sensitivity analysis shows how, and how much, the results change as a consequence of different assumptions regarding crucial variables: discount rate, reference period of the analysis, frequency of screening, age of the target population, volume of activity of each screening unit, compliance, sensitivity and specificity of the test.

Breast Neoplasms↗

[Perinatal fetal distress: correlations between Apgar score at birth and assay of CK-BB in umbilical cord blood].

32 newborn infant's umbilical cord blood CK-BB activity was tested at birth. 14 of them had a superior to 7 Apgar score at first and fifth minutes, whereas 18 newborn infant Apgar score was inferior to 7. The CK-BB activity was significantly higher in newborn infants having a low Apgar score at birth. A low Apgar score at first and fifth minutes together with a high CK-BB activity must be considered a nervous trouble signal and a warning in order to look after children's psychomotor skills more strictly and individual neurological damage.

Apgar Score↗

[Cost-effectiveness analysis of extracorporeal lithotripsy].

The recent introduction of extracorporeal lithotripsy (ECL) for the treatment of urinary stones has raised new questions for doctors and economic policy decision makers. This study presents a cost-effectiveness analysis of extracorporeal lithotripsy conducted in an Italian hospital which has used a Sonolith 3000 lithotriptor since 1989. The overall cost of treatment by ECL (of a simple case of urinary stones) is 5,080 FF and the cost per cured case (taking into account the number of sessions per patient and the percentage of cured cases) varies between 6,200 FF and 9,500 FF. The results obtained (influenced by the lack of certain clinical data due to the recent use of this technique) appear to be in favour of extension of ECL treatments in comparison with surgical treatment due to their lower cost, lower morbidity and shorter convalescent period.

Cost-Benefit Analysis↗

[Cost-benefit analysis of a mammography screening program extended to all the national territory].

A cost-effectiveness analysis has been conducted in order to evaluate effects and costs of a nationwide mammographic breast cancer screening programme compared with no screening in a 30 years period. The analysis includes seven different phases of breast cancer, from the screening programme itself to the treatment of terminal illness. The estimates use italian published data and field studies. The calculations were performed with the Miscan computer simulation package: a programme providing for the screening of women aged 50-69 at two years intervals might be expected to result in a 1,650 deaths prevented and 14,500 years of life gained each year. The overall net costs of the programme were assessed at between 2,893 and 3,212 thousand million lire, the cost per life saved between 59.8 and 66.4 million lire and the cost per life-year gained between 6.6 and 7.3 million lire (between 10.7 and 11.5 million lire with a 5% discount rate, an estimate lower than that of German programme). The analysis produces important information for the Italian policy debate over mammography and it also contributes to the development of economic evaluation in our country.

Aged↗